Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TAK-062
TAK-062
Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million
BioSpace
Wed, 02/26/20 - 10:34 am
Takeda
PvP Biologics
celiac disease
M&A
TAK-062